You are using an old and unsupported browser. Upgrade to a modern browser for a better experience

Times are shown in your local time zone (GMT )
Boehringer Ingelheim Animal Health

Boehringer Ingelheim Animal Health

About Boehringer Ingelheim Animal Health
The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 10,000 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both. Respect for animals, humans and the environment is at the heart of what we do. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society-threatening diseases. Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with a presence in more than 150 countries. Entering the Vetfest Passport Competition? If so you will find the special code for Week 3 in the brochure for Vetplus - Australia's Premier Veterinary Business Support Program, available to download from the resources below.
Add to Favourites


This technical range brochure provides a review of the core and non-core pathogens of dogs, and things to consider when reviewing your canine vaccination protocol.
This technical range brochure provides a review of the core and non-core pathogens of cats, and things to consider when reviewing your feline vaccination protocol.
Written by Dr Allison Stewart, this technical bulletin provides an overview of pain management for equine practitioners, including a review of commonly used NSAIDs. As a companion to this bulletin, Allison will be presenting a case-based webinar on the 18th August - see the final page for more details.
Learn more about developing a parasite control protocol for your clinic and the new 'NexGard Let's Go' SMS treatment reminder service to maximise client compliance.
This new diagnostic algorithm, produced by the Australasian Veterinary Cardiology Advisory Board, incorporates a simplified radiographic measurement technique (Vertebral Left Atrial Size) to help you determine whether a dog has stage B2 MMVD, and should therefore be treated with Vetmedin.
Did you know a recent meta-analysis estimated that 7% of Australians have anti-Toxocara antibodies, indicating current or prior infection? This technical update reviews the biology of this common parasite and the growing body of evidence of its significant impact on human health. Importantly, learn about strategies you can implement with your clients to minimise the risk.
Developed by the Australian Paralysis Tick Advisory Panel, the updated 2020 guidelines provide best practice evidence-based advice on managing tick paralysis in dogs and cats.
Learn about how Vetplus can help your business - from free bespoke websites to digital and print marketing tools.
Boehringer Ingelheim, in association with veterinarians from University of Queensland and Randwick Equine Centre, are conducting an Australia-wide survey on pain management in horses, in both hospital and ambulatory practice. We are looking for insights on how you currently assess and manage peri-operative, post-surgical and chronic pain. With your help we can further understand and optimise practices and outcomes for equine pain management. Download to find out more.
#VetFest 2020
VetFest 2020
#VetFest 2020